In patients with advanced tumors, some inflammatory factors such as tumor necrosis factor alfa, interleukin 6, and interleukin 1 beta can induce the synthesis of CRP in hepatocytes while promoting angiogenesis to support tumor growth and anti-apoptosis capabilities to protect tumor cells. Here, IL1B is linked to neoplasm.